IP Library Granted Patent US 7,239,912
Granted Patent B2
US 7,239,912 · App. 10/243,612 · Granted Jul 3, 2007

Electric modulation of sympathetic nervous system

Assignee: Leptos Biomedical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,239,912
App. No.
10/243,612
Granted
Jul 3, 2007
Kind
B2
Abstract

A method for the treatment of obesity or other disorders, by electrical activation or inhibition of the sympathetic nervous system. This activation or inhibition can be accomplished by electrically stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using an implantable pulse generator. This nerve activation can result in reduced food intake and increased energy expenditure. Reduced food intake may occur through a variety of mechanisms that reduce appetite and cause satiety. Increased adrenal gland hormone levels will result in increased energy expenditure. Fat and carbohydrate metabolism, which are also increased by sympathetic nerve activation, will accompany the increased energy expenditure.

Claims (13)

1. A method for inducing weight loss in a patient, comprising:

providing a pulse generator that emits electrical pulses in a programmable stimulation pattern;

wherein the stimulation pattern is programmable to achieve weight loss in the patient from electrical activation of a splanchnic nerve of the patient; and

wherein the stimulation pattern is further programmable to keep the patient's blood pressure within safe limits during the electrical activation of the splanchnic nerve;

electrically activating the splanchnic nerve of the patient with said pulse generator using said stimulation pattern so as to achieve weight loss and keep the patient's blood pressure within safe limits;

wherein the splanchnic nerve is selected from the group consisting of the greater splanchnic nerve, the lesser splanchnic nerve, and the least splanchnic nerve; and

programming said stimulation pattern so as to achieve weight loss in the patient and so as to keep the patient's blood pressure within safe limits during electrical activation of the splanchnic nerve.

2. The method of claim 1 , wherein the electrically activating comprises:

implanting the pulse generator within a patient, said pulse generator having programmable signal-on and signal-off times; and

applying a current pulse to the splanchnic nerve in the patient with said pulse generator.

3. The method of claim 2 , further comprising:

programming said signal-on and signal-off times to keep the patient's blood pressure within safe limits.

4. The method of claim 3 , wherein said signal-off time is greater than or equal to said signal-on time.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2010
From: LEPTOS BIOMEDICAL INC.
To: ADVANCED NEUROMODULATION SYSTEMS, INC. D/B/A ST. JUDE MEDICAL NEUROMODULATION DIVISION
Reel/Frame 024369/0898 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2002
From: DOBAK, JOHN D., III
To: LEPTOS BIOMEDICAL, INC.
Reel/Frame 013585/0787 →
Continuity (6)
Provisional Application 6036675000 · Mar 22, 2002
Provisional Application 6037031100 · Apr 5, 2002
Provisional Application 6037960500 · May 10, 2002
Provisional Application 6038421900 · May 30, 2002
Provisional Application 6038669900 · Jun 10, 2002
Related Publication 20030181958A1 · Sep 25, 2003